Clinical Trial Update: Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing empagliflozin plus linagliptin versus metformin plus insulin glargine in type 2 diabetes focusing on renal and vascular changes; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin + Linagliptin
• Metformin + Insulin Glargine

Snippet

Sponsor: Institut für Pharmakologie und Präventive Medizin | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED